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Introduction
Neurological disorders are a common health prob-
lem affecting people of different ages and sexes all 
around the world. During the last decades, despite 
innovative treatments and early detection, both the 
prevalence and the number of disability-adjusted 
life-years of the population with neurological disor-
ders continue to increase [1]. All of the neurologi-
cal disorders which affect the central nervous sys-
tem are associated with a decrease in quality of life, 
higher disability, and a loss of functional perfor-
mance, such as gait difficulties [2].
Parkinson’s disease (PD) is the most frequent 
neurological affectation in the elderly, along with 
dementia [2]. Prevalence in industrialized countries 
is estimated between 0.3-1% in subjects older than 
60 years, and 3% in people over 80 years of age, with 
incidence rates of between 0.08 and 0.18 per 1,000 
people/year [3]. PD is a progressive illness associ-
ated with the death of dopamine-producing cells, 
causing an imbalance between neurotransmitters 
due to an increase in acetylcholine and glutamate 
[4]. It mainly affects a person’s movements, charac-
terized by tremor, rigidity, and bradykinesia, caus-
ing muscle weakness and balance alteration [5,6]. 
This neurological disease affects gait with a gait 
pattern frequently altered, leading to difficulties in 
daily activities. Nowadays, the standard physiothera-
py treatment consists of improving balance skills, 
strength, and coordination by teaching simple exer-
cises [7], combining with robotic gait assistance when 
possible [8].
This study used a rehabilitation approach that 
combines immersive virtual reality with a treadmill 
providing mechanical body weight support thanks 
to a system of harnesses and pulleys. Treadmill train-
ing is considered an effective intervention to im-
prove gait endurance [9] and gait parameters such as 
gait speed, stride length [9,10] in patients with PD, 
without additional risk compared to standard phys-
iotherapy treatment [10]. In parallel, virtual reality 
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Introduction. Treadmill training is considered an effective intervention to improve gait ability in patients with Parkinson’s 
disease (PD). In parallel, virtual reality shows promising intervention with several applications in the inpatient medical 
setting. 
Aim. To evaluate the feasibility and preliminary efficacy of mechanical gait assistance combined with immersive virtual 
reality in patients with PD. 
Patients and methods. This pilot and feasibility study followed a pre-post study design. The intervention consisted of 12 
sessions of 30 minutes, distributed regularly over four consecutive weeks. Participants walked on a treadmill with a body-
weight support system set at approximately 20% of body weight and equipped with a virtual reality helmet controlled by a 
two-handed joystick. Feasibility and intervention outcomes were collected at baseline and after four weeks of intervention. 
Results. Twelve participants of 60 patients were finally enrolled. Nine of them (75%) completed the treatment intervention 
with an adherence rate of 97%. Two participants left the study, one of them due to sickness associated with virtual reality 
and another because of a lack of motivation. There were significant differences associated with small-medium effect sizes 
when comparing the pre and post values for walk distance, walk speed, balance, and quality of life. 
Conclusions. The present study provided preliminary evidence supporting the feasibility of the combination of antigravity 
treadmill and immersive virtual reality system for the rehabilitation of patients with PD.
Key words. Gait. Parkinson’s disease. Physical therapy. Quality of life. Treadmill training. Virtual reality.
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shows promising interventions with several applica-
tions in the inpatient medical setting [11]. Indeed, 
rehabilitation with virtual reality allows the person 
to work on locomotion disorders, gait, and balance, 
as well as any other diseases. Virtual reality is noted 
as a potential therapeutic tool to improve balance 
and gait ability [9,12,13] in patients with PD without 
any associated adverse effects [14]. The combination 
of both existing treatment procedures may provide 
innovation in neurologic rehabilitation, therefore 
becoming an alternative to the standard physiother-
apy methods for gait rehabilitation. The innovative 
treatment resulting from joining mechanical, prop-
rioceptive, and immersive visual stimuli could have 
more effect at the central level, and thus improve the 
autonomy and independence of individuals. Besides, 
there are no previous studies in patients with PD or 
other adult neurological populations which have 
considered this therapeutic combination. This study 
aimed to evaluate the feasibility and preliminary ef-
ficacy of mechanical gait assistance combined with 
immersive virtual reality in patients with PD.
Patients and methods
Study design
This pilot and feasibility study followed a pre-post 
study design [15], approved by the Ethics Committee 
of Aragon (CEICA) with registration number C.P.-
C.I. PI18/386 and registered in ClinicalTrials.gov 
with the identifier NCT04117737. 
Patients
Each patient was informed about the nature of the 
study, objectives, and voluntary participation, as 
well as possible adverse effects that may occur dur-
ing its implementation, such as muscle fatigue, sick-
ness, or nausea. Each participant signed informed 
consent before participating in the study.
Inclusion criteria were: diagnosis of PD by a 
neurological doctor; an alteration of the gait but 
being able to walk independently for a distance of 
at least 10 meters; a height higher than 150 cm; be-
ing more than 18 years old. Exclusion criteria were: 
being blind; having medical contraindications for 
walking; being an amputee; a history of intake of 
alcohol-drugs; presenting other diseases that im-
pede the intervention. Withdrawal criteria were: 
experiencing pain during walking that changed the 
gait pattern; refusal to continue; missing more than 
two interventions or one assessment.
Procedure
The study was executed in the Aragon Association 
of Parkinson (Zaragoza, Spain) for patients with PD. 
The association informed all their members of the 
possibility of participating through internal com-
munication methods. Those patients who reported 
their willingness to participate in the study were 
codified with a consecutive number. Participants 
were consecutively assessed for eligibility according 
to a randomized list. Participants who fulfilled the 
inclusion criteria were enrolled in the intervention 
group. Every participant was assessed for all inter-
vention outcomes at baseline (hereafter called ‘pre’) 
and after 4-weeks (hereafter called ‘post’), precisely 
three days after the end of the intervention pro-
gram. The intervention began just after the baseline 
assessment was completed.
Intervention
The intervention consisted of 12 sessions of 30 min-
utes, distributed regularly over four consecutive 
weeks (3 sessions per week) [16-19]. Sessions con-
sisted of walking at a self-selected comfortable 
walking speed on a treadmill with a body-weight 
support system set at approximately 20% of body 
weight and equipped with a virtual reality helmet 
controlled by a two-handed joystick (Motigravity, 
manufactured by Aldebran; Curno, Italy) (Fig. 1). 
Before and after each training session, participants 
performed warm-up and cool-down exercises of 
5-minutes each. The body-weight support discharge 
was selected, taking into account previous studies 
[18-21]. The virtual environment consisted of a 
Martian landscape with dunes, rocks, and buildings, 
allowing slope changes, obstacles, and barriers, re-
spectively (Fig. 2). The virtual reality system was 
controlled via the two-handed joystick device and 
was independent of the treadmill speed. The joy-
sticks offered the ability to use both hands, further 
enhancing virtual reality interaction and dual-task 
rehabilitation. The patient was told to explore the 
landscape and move forward by pushing both joy-
sticks simultaneously in the forward direction. At 
the same time, the patient was instructed to push 
both joysticks simultaneously to the right or the left 
to change the direction and overcome obstacles. 
The patient’s representation in the virtual reality 
system was designed to stop when there was no in-
teraction with the joysticks, although the treadmill 
follows running. Each patient was asked to select 
their comfortable speed during the warm-up. Nev-
ertheless, the physiotherapist responsible for the 
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intervention adjusted the velocity during each ses-
sion, depending on the patient’s perception and fa-
tigue.
Measures
Sociodemographic and clinical variables
Patient’s sociodemographic data (gender, age, height, 
weight) and clinical data (modified Hoehn and Yahr 
staging scale [22], number of hours walking by day, 
number of falls during the last week) were collected 
at baseline.
Feasibility of recruitment and protocol adherence
Rates of recruitment, eligibility, and adherence to 
the intervention were registered. One week after 
the end of the intervention program, an indepen-
dent evaluator, blinded to the intervention and the 
assessment, conducted a short interview regarding 
the participants’ satisfaction and acceptability of 
assessment and intervention procedures. Partici-
pants rated their level of satisfaction with the inter-
vention in a 5-points Likert scale (0: ‘very dissatis-
fied’; 1: ‘quite dissatisfied’; 2: ‘neither satisfied nor 
dissatisfied’; 3: ‘quite satisfied’; 4: ‘very satisfied’).
Intervention outcomes for  
investigating preliminary efficacy
All outcome measures, at Pre and Post assessments, 
were evaluated by a single physiotherapist trained 
in the protocol. All evaluations were performed when 
participants were in the ‘on’ medication state, ap-
proximately one hour after the intake of their regu-
lar medication [23].
The primary outcome for investigating prelimi-
nary efficacy was gait distance, in meters, by using 
the 6 Minute Walk Test (6MWT). This test consists 
of measuring the maximum distance that the sub-
ject can walk a flat surface for 6 minutes [24].
Secondary outcomes for investigating preliminary 
efficacy were gait speed, balance, and quality of life.
Gait speed, in meters per second, was assessed 
by using the 10 Meter Walk Test (10MWT). This 
test consists of asking the subject to walk at a com-
fortable speed a 14-meters distance on a flat surface 
and measuring the time spent from meter 2 to me-
ter 12 (to remove the increase and decrease velocity 
phases) [25].
The balance level was estimated by using the Ti-
netti scale. The Tinetti test is a simple and repro-
ducible scale which is composed of two subscales, 
the balance and gait sections. The balance section is 
performed in sitting and standing positions and 
covers a maximum of 16 points, while the gait sec-
tion is performed by walking and represents a max-
imum of 12 points. Total scores over 24 points indi-
cate a low risk of falls, while scores under 18 points 
indicate a high risk of falls [26].
Quality of life was assessed by using the 36-Item 
Short-Form Health Survey (SF-36) [27]. SF-36 as-
sesses eight physical and mental health domains: 
limitations in physical activities because of health 
problems (physical functioning); limitations in so-
cial activities because of physical or emotional 
problems (social functioning); limitations in usual 
role activities because of physical health problems 
(role physical); bodily pain (bodily pain); psycho-
Figure 1. Experimental image of a patient walking on the Motigravity system. a) Posterior view; b) An-
terior view.
a b
Figure 2. Representative images of the virtual environment. The environment consisted of a Martian 
landscape with rocks and buildings (a) or dunes (b).
a b
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logical distress and well-being (mental health); lim-
itations in usual role activities because of emotional 
problems (role emotional); energy and fatigue (vi-
tality); and general health perceptions (general health). 
For each scale, item scores are coded, summed, and 
transformed, with final values expressed as a per-
centage ranging from 0 (worst health) to 100 (best 
health).
Sample size
An estimated pilot study sample size was conduct-
ed using G*Power v. 3.1.9.2 software, taking into ac-
count previous data of minimal detectable change 
for the 6MWT in the population with PD [24]. A 
total sample of 12 participants was required expect-
ing an improvement considered as large effect size 
(Cohen’s d = 0.8), with a significance level of 0.05 
and a power of 80%.
Statistical analysis
Descriptive statistics were used to report data on 
the feasibility of recruitment and protocol adher-
ence. Variables were described in mean and stan-
dard deviation or median and interquartile range. 
An intention to treat analysis was made by carrying 
forward the last value. The Shapiro-Wilk test of 
normality showed that intervention variables did 
not follow a normal distribution. Therefore, the 
Wilcoxon signed-rank test was used to determine 
any difference between pre and post assessment 
scores for all intervention outcomes. The signifi-
cance level was set at p < 0.05. Cohen’s d was calcu-
lated by the standardized difference between pre 
and post means (small effect: 0.2; medium effect: 
0.5; large effect: 0.8) in those patients who complet-
ed the intervention. The statistical analysis was per-
formed with SPSS Statistics v. 25 software.
Results
The participants’ flow diagram is presented in fig-
ure 3. Recruitment commenced in September 2019 
and was completed by November 2019. Of the 60 
potential participants who were invited to partici-
pate at Parkinson Aragon, 32 (54%) reported their 
willingness to participate. Potential participants were 
numbered and randomly allocated to reach the a 
priori sample size estimation. Thirteen patients were 
assessed for eligibility, and one of them was exclud-
ed because the participant was not able to wear the 
harness due to obesity. In total, nine participants 
(75%) completed the treatment intervention and were 
assessed at the 4-week follow-up. The adherence 
rate, calculated as the ratio between the sessions 
performed and the sessions scheduled (12 sessions), 
was 97%. Dropouts across the study were due to 
sickness associated with virtual reality after two 
sessions of intervention (n = 2) and because of lack 
of motivation after three sessions of intervention 
(n = 1). The three dropouts were male and had a 
score of 2-2.5 on the modified Hoehn and Yahr 
staging scale. Amongst the nine participants who 
completed the intervention, seven of them reported 
being ‘very satisfied’ with the intervention, while two 
were ‘quite satisfied’. Participants favorably high-
lighted the security sensation of the body weight 
support at the same time they had to perform the 
dual-task consisting of walking over the treadmill 
and controlling the virtual reality system with the 
joystick devices. In contrast, the main suggestion of 
improvement concerned the Martian landscape, 
which sometimes was considered monotonous.
Participants had a mean age of 68.8 ± 7.7 years, 
and 58% were male. The mean weight was 70.2 ± 
15.2 kg, and the mean height was 162.6 ± 8,2 cm. 
According to the modified Hoehn and Yahr staging 
Figure 3. Flow chart.
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scale, there were four participants (33%) at stage 2, 
three participants at stage 2.5 (25%), four partici-
pants (33%) at stage 3, and one participant (8%) at 
stage 4. They reported a mean of 7.5 ± 4.9 hours of 
walking per week and a median of 0 falls per week 
(interquartile range: 0-1).
Table shows median scores for intervention out-
comes at both time points. Significant differences 
were observed when comparing the pre and post val-
ues for distance (p = 0.005; effect size: 0.3) at 6MWT, 
for speed (p = 0.047; effect size: 0.2) at 10MWT, for 
balance (p = 0.044; effect size: 0.6) at the Tinetti 
scale, and for physical functioning (p = 0.027; effect 
size: 0.4), role physical (p = 0.049; effect size: 0.6) 
and bodily pain (p = 0.018; effect size: 0.5) at SF-36. 
Figure 4 shows individual changes in the 6MWT, 
10MWT, and Tinetti scale for participants who ful-
filled the treatment intervention.
Discussion
This study evaluated the feasibility and preliminary 
efficacy of an antigravity treadmill combined with 
immersive virtual reality for gait rehabilitation in 
patients with PD. The main findings suggested that 
12 sessions of 30 minutes, over four weeks, were 
acceptable and feasible to deliver in persons with 
PD. Participants presented excellent adherence to 
the interventions and reported high levels of satis-
faction with the intervention. The study also pro-
vides preliminary evidence to suggest that the in-
tervention may have a positive impact on gait dis-
tance, gait speed, and quality of life.
Similar protocols of 3 sessions per week of 30-45 
minutes treadmill training during four weeks re-
vealed improvements in gait ability [17-19], motor 
function, balance [16,28], cognitive parameters, and 
depression [17] in patients with PD. Other studies 
found similar results to ours for the 6MWT, such as 
Picelli et al. [17] that reported an improvement of 
36 meters during four consecutive weeks of tread-
mill training, Nadeau et al [29] that showed an in-
crease between 34 to 40 meters and 29 to 44 meters 
in a period of 12-weeks and 24-weeks, respectively. 
In this line, de Melo et al [30] obtained an improve-
ment of approximately 52 to 87 meters after a 
3-weekly session during 4-weeks of treadmill train-
ing or intervention of immersive virtual reality com-
pared to a control group. However, they did not ex-
plore the effect of combined interventions.
Concerning our secondary outcomes, post-treat-
ment speeds in the 10MWT were similar to previous 
studies that implemented either treadmill [17,18,21, 
28] or virtual reality [31] independently. Neverthe-
less, improvements were inferior because our base-
line values were already high. The high baseline 
scores could indicate a ceiling effect that made it 
difficult to find differences in the pre and post val-
ues. Something similar may have occurred concern-
ing the Tinetti scale, as initial scores were higher 
than baseline values reached in previous studies in 
PD [20,26].
Previous studies have shown the effectiveness of 
virtual reality training in gait [23,30-32], balance 
[31,32], and cognitive function [33], but without 
the integration of an antigravity mechanical sup-
port system. According to the authors’ knowledge, 
there are no previous studies that combined an an-
tigravity treadmill with immersive virtual reality in 
patients with PD. In this context, Mirelman et al 
[34] found that an intervention of 3-weekly sessions 
over six weeks, based on non-immersive virtual re-
ality combined with a medical treadmill, reduced 
the risk of falls in older adults in the long term, in-
cluding a sub-group of patients with PD. One year 
later, Peruzzi et al [35] compared the same treat-
Table. Median scores and interquartile range for study variables at pre and post-assessments.
Pre (n = 12) Post (n = 12) p ES
6MWT (m) 326 (181-379) 374 (201-394) 0.005 a 0.3
Tinetti: total (0-28) 24 (20.8-25.8) 26 (23.5-27.8) 0.044 a 0.6
Tinetti: gait section (0-12) 11 (9.3-12) 12 (11-12) 0.123 0.6
Tinetti: balance section (0-16) 13.5 (11.3-14) 14.0 (12.3-15.8) 0.066 0.5
10MWT (m/s) 1.38 (0.85-1.64) 1.39 (0.90-1.65) 0.047 a 0.2
Physical functioning (SF-36, 0-100) 48 (21-68) 60 (41-83) 0.027 a 0.4
Social functioning (SF-36, 0-100) 63 (50-72) 69 (41-85) 0.263 0.4
Role physical (SF-36, 0-100) 41 (9-74) 63 (31-75) 0.049 a 0.6
Bodily pain (SF-36, 0-100) 46 (24-65) 63 (27-82) 0.018 a 0.5
Mental health (SF-36, 0-100) 48 (41-56) 52 (45-64) 0.212 0.4
Role emotional (SF-36, 0-100) 67 (35-98) 67 (50-100) 0.246 0.4
Vitality (SF-36, 0-100) 38 (19-45) 43 (35-50) 0.065 0.6
General health (SF-36, 0-100) 38 (30-56) 45 (35-54) 0.234 0.3
6MWT: 6 Minute Walk Test; 10MWT: 10 Meter Walk Test; ES: effect size; SF-36: 36-Item Short-Form Health Sur-
vey. a Significant differences between pre and post after Wilcoxon signed-rank test (p < 0.05).
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ment against a treadmill-only based intervention in 
patients with multiple sclerosis and found that the 
dual-task intervention was effective in improving 
balance and spatiotemporal parameters of gait.
On the one hand, the improvement of patients 
in this study may be due to the benefits of treadmill 
training, which simulate the task of walking, im-
proving motor learning, and strength of the lower 
extremities. On the other hand, dual-task with the 
virtual reality system could have contributed to im-
proving motor function as well as the self-percep-
tion of the patients with PD [36].
Our pilot study followed a pre-post study design, 
which has the strength of temporality to be able to 
suggest that the outcome is impacted by the inter-
vention [15]. However, a randomized controlled trial 
design would have been a better alternative due to 
pre-post studies not having control over other ele-
ments that are also changing at the same time as 
the intervention is implemented. Nevertheless, chron-
ic diseases, such as PD, with extended periods of 
stability of clinical signs and symptoms, provide 
certainty that outcomes improvements are attrib-
uted to the specific intervention rather than the 
natural evolution of the disease [15]. Also, cogni-
tive parameters should have been considered [37]; 
thus, cognitive impairment may have a substantial 
contribution to the manifestation in different pa-
rameters of gait in PD [38].
The present pilot study suggested that an inter-
vention of 12 sessions over four weeks of antigravity 
treadmill combined with an immersive virtual real-
ity system was feasible to deliver and acceptable for 
the rehabilitation of patients with PD. Preliminary 
evidence suggested that the proposed intervention 
has a positive effect on increasing gait distance, gait 
speed, balance, and quality of life. Future studies 
should evaluate the impact in the long term, with a 
randomized control trial design, considering both 
physical functioning and cognitive variables.
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Entrenamiento antigravitatorio e inmersivo de realidad virtual para la rehabilitación de la marcha en la 
enfermedad de Parkinson: estudio piloto y de viabilidad
Introducción. El entrenamiento en tapiz rodante se considera una intervención eficaz para mejorar la capacidad de la 
marcha en pacientes con enfermedad de Parkinson (EP). Paralelamente, la realidad virtual se muestra como una inter-
vención prometedora con diversas aplicaciones en el entorno médico hospitalario. 
Objetivo. Evaluar la viabilidad y la eficacia preliminar de la asistencia mecánica para la marcha combinada con la realidad 
virtual inmersiva en pacientes con EP. 
Pacientes y métodos. Este estudio piloto y de viabilidad siguió un diseño pre-post. La intervención consistió en 12 sesiones 
de 30 minutos, distribuidas regularmente durante cuatro semanas consecutivas. Los participantes deambularon sobre un 
tapiz rodante con un sistema de descarga del peso corporal establecido aproximadamente en el 20% del peso corporal y 
equipados con un casco de realidad virtual controlado por un joystick para cada mano. Las mediciones de viabilidad y tra-
tamiento se recopilaron al inicio del estudio y después de cuatro semanas de intervención. 
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Resultados. De un total de 60 pacientes, se reclutó finalmente a 12 participantes. Nueve de ellos (75%) completaron el trata-
miento, con una tasa de adhesión del 97%. Dos participantes abandonaron el estudio, uno debido a náuseas asociadas con la 
realidad virtual y otro por falta de motivación. Hubo diferencias significativas asociadas con un tamaño del efecto pequeño-
mediano al comparar los valores pre y post para la distancia recorrida, velocidad de la marcha, equilibrio y calidad de vida. 
Conclusiones. El estudio proporcionó evidencia preliminar que apoya la viabilidad de la combinación de un tapiz rodante 
antigravitatorio y un sistema de realidad virtual inmersivo para la rehabilitación de pacientes con EP.
Palabras clave. Calidad de vida. Enfermedad de Parkinson. Entrenamiento en tapiz rodante. Fisioterapia. Marcha. Realidad 
virtual.
